Mother urges for approval of Sarepta drug to help son, Rutland Herald reports Jennifer NcNary, who has two sons with Duchenne muscular dystrophy, one in the clinical trial for eteplirsen and one not, has recently petitioned the FDA to give the Sarepta (SRPT) drug accelerated approval so that her other son can benefit from it. Reference Link
News For SRPT From The Last 14 Days
Check below for free stories on SRPT the last two weeks.